AFP and portal hypertension: First, as with all retrospective studies, there was some selection bias, including differences among patients regarding treatment decisions and the presence of incomplete data including alpha-fetoprotein, vascular invasion, extrahepatic metastases, performance status, and clinically relevant portal hypertension.